Currently out of the existing stock ratings of Joanne Wuensch, 275 are a BUY (64.1%), 137 are a HOLD (31.93%), 17 are a SELL (3.96%).

Joanne Wuensch

Work Performance Price Targets & Ratings Chart

Analyst Joanne Wuensch, currently employed at CITI, carries an average stock price target met ratio of 70.77% that have a potential upside of 16.32% achieved within 198 days.

Joanne Wuensch’s has documented 853 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on IART, Integra LifeSciences Holdings at 05-Nov-2024.

Wall Street Analyst Joanne Wuensch

Analyst best performing recommendations are on SGHT (SIGHT SCIENCES).
The best stock recommendation documented was for GKOS (GLAUKOS CORP) at 3/4/2020. The price target of $40 was fulfilled within 1 day with a profit of $2.27 (5.37%) receiving and performance score of 53.7.

Average potential price target upside

of $53.93 (19.23%) on ISRG (INTUITIVE SURGICAL).
of $41.22 (20.8%) on PEN (PENUMBRA).
of $43 (13.74%) on PODD (INSULET).

ABT Abbott Laboratories ALC Alcon AG BAX Baxter International BDX Becton Dickinson and Company BSX Boston Scientific Corp COO The Cooper Companies . Common Stock DXCM DexCom EW Edwards Lifesciences Corp GKOS Glaukos Corp HAE Haemonetics IART Integra LifeSciences Holdings IRT Independence Realty Trust IRTC iRhythm Technologies ISRG Intuitive Surgical JNJ Johnson & Johnson LUNG Pulmonx Corp MDT Medtronic PLC NUVA NuVasive NVRO Nevro Corp PEN Penumbra PODD Insulet RMD ResMed SILK Silk Road Medical SYK Stryker TNDM Tandem Diabetes Care ZBH Zimmer Biomet Holdings SGHT Sight Sciences WMGI Wright Medical Group N.V ITGR Integer Holdings Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Matt Miksic (BARCLAYS)